Lv11
40 积分 2025-08-15 加入
Targeting spleen tyrosine kinase (SYK): structure, mechanisms and drug discovery
2小时前
已完结
Discovery of INCB123667, a potent and selective cyclin-dependent kinase 2 (CDK2) inhibitor for the treatment of cyclin E dysregulated cancers
4天前
已完结
Discovery of potent and selective CDK2 inhibitors with high safety and favorable bioavailability for the treatment of cancer
4天前
已完结
皖公网安备34019202002308
